Clinical impact of microbiological results in two-stage revision arthroplasty with spacer exchange

Bernhard J H Frank1,2, Sebastian Simon1,2, Alexander Aichmair1,2

  • 1Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, Speisinger Strasse 109, 1130, Vienna, Austria.

Abstract

Insights

Spacer exchange in two-stage revision arthroplasty for periprosthetic joint infections (PJI) shows frequent microbiological changes. Successful eradication of infection at reimplantation leads to comparable re-revision rates to standard two-stage procedures.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Microbiology

Background:

  • Two-stage revision arthroplasty for periprosthetic joint infections (PJI) has high failure rates, particularly when a spacer exchange is necessary.
  • Limited understanding exists regarding the impact of microbiological findings and evolving resistance patterns in patients undergoing spacer exchange.

Purpose of the Study:

  • To investigate the clinical significance of microbiological results and resistance pattern changes in patients requiring spacer exchange during two-stage revision arthroplasty.
  • To compare re-revision and re-infection rates between patients undergoing spacer exchange and those treated with standard two-stage procedures.

Main Methods:

  • Analysis of 312 patients (327 procedures) from 2011-2019, with a focus on 52 patients requiring spacer exchange.
  • Evaluation of microbiological spectrum, antibiotic resistance, host factors, and re-revision/re-infection rates.
  • Propensity score-matched analysis comparing spacer exchange patients with standard two-stage procedure patients.

Main Results:

  • High rates of microbiological spectrum changes (up to 83.3%) were observed between surgical stages in patients with multiple positive cultures.
  • Antibiotic resistance patterns shifted in 66.7% of patients with repeated microorganism detection.
  • Culture-positive reimplantations had significantly higher re-infection rates (83.3%) compared to culture-negative reimplantations (5%).
  • No significant differences in re-revision (25% vs. 25%) or re-infection (23.1% vs. 15.4%) rates were found between patients with and without spacer exchange.

Conclusions:

  • Microbiological spectrum and antibiotic resistance pattern changes are common during the interval in patients needing spacer exchange.
  • Achieving microbiological eradication at reimplantation is crucial for comparable re-revision outcomes to standard two-stage procedures.

Related Concept Videos